Trial evidence about weight loss does not prove a direct skin benefit or harm
doi: 10.1001/jama.2023.13872
Semaglutide is available as both an injectable and an oral pill, effectively mimicking the GLP-1 hormone to suppress appetite and promote sustained weight loss
The intermediates from de novo lipogenesis in the liver will disrupt mitochondrial function and produce ROS, and then cause endoplasmic reticulum (ER) stress, ultimately leading to inflammation, and the broken cells releasing cytokines will cause more cell death (Huang et al., 2025)
A provider may review medical history, medications, weight-loss history, blood sugar markers, cardiovascular risk, gallbladder history, digestive symptoms, kidney or liver concerns, and nutrition status
Ozempic (semaglutide) injection prescription label